BrightGene Bio-Medical Technology Co

BrightGene Bio-Medical Technology Co Dividend per Share

The Dividend per Share of BrightGene Bio-Medical Technology Co (688166.SS) as of Nov 2, 2026 is 0.10 CNY. In the previous year, Dividend per Share was 0.10 CNY — a change of 0.00% (lower).

Dividend per Share

0.10CNY

YoY

0.00%

Last updated:

Dividend per Share of BrightGene Bio-Medical Technology Co is 2025 0.10 CNY. Dividend per Share of BrightGene Bio-Medical Technology Co was 2024 0.10 CNY. It decreases by 0.00% lower compared to the previous year.

At today's price the dividend yield works out to roughly 0.32%. The payout ratio is around 75% of earnings. The dividend has grown at 3.2% per year over the past 5 years.

The BrightGene Bio-Medical Technology Co Dividend per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend per Share
Date
Dividend per Share
Jan 1, 2023
0.11 CNY
Jan 1, 2024
0.10 CNY
Jan 1, 2025
0.10 CNY
Jan 1, 2026 (e)
0.02 CNY
Jan 1, 2027 (e)
0.02 CNY
Jan 1, 2028 (e)
0.02 CNY
Jan 1, 2029 (e)
0.02 CNY
Jan 1, 2030 (e)
0.02 CNY
The BrightGene Bio-Medical Technology Co Dividend per Share history
YEARDividend per ShareYoY
est0.02CNY0.00%
est0.02CNY0.00%
est0.02CNY0.00%
est0.02CNY0.00%
est0.02CNY-83.33%
0.10CNY0.00%
0.10CNY-15.79%
0.11CNY-5.00%
0.12CNY+42.86%
0.08CNY+2.44%
0.08CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

BrightGene Bio-Medical Technology Co Stock analysis

What does BrightGene Bio-Medical Technology Co do? BrightGene Bio-Medical Technology Co., Ltd. generates revenue by researching, developing, and manufacturing biopharmaceuticals, medicines, and special generic active pharmaceutical ingredients and finished dosage forms. The company's product portfolio centers on antifungal, antiviral, and immunosuppressive APIs, alongside other APIs and preparations. Its generic drug offerings specifically include entecavir, caspofungin, micafungin, posaconazole, everolimus, and fondaparinux sodium. The firm sells these products to customers in both domestic and overseas markets. By leveraging its capabilities in producing essential active pharmaceutical ingredients and finished dosage forms, the company serves the broader pharmaceutical sector through its established manufacturing and research operations. BrightGene Bio-Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BrightGene Bio-Medical Technology Co stock

Dividend per Share of BrightGene Bio-Medical Technology Co is 0.10 CNY in 2025.

Dividend per Share of BrightGene Bio-Medical Technology Co changed from 0.10 CNY to 0.10 CNY, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Dividend per Share BrightGene Bio-Medical Technology Co since 2006 – with annual values, charts, and detailed analysis.

Dividend per share is the total dividend payment divided by shares outstanding. It shows how much cash each share receives in dividends.

Dividend per Share's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend per Share's BrightGene Bio-Medical Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Dividend — BrightGene Bio-Medical Technology Co

DividendDividend YieldDividend per ShareYears Dividend PaidYears Dividend Not DecreasedYears Dividend IncreasedDividend Coverage

All Key Metrics — BrightGene Bio-Medical Technology Co